HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shigetaka Yoshida Selected Research

Salts

8/2014Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
6/2012Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation.
8/2011Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway.
6/2006Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shigetaka Yoshida Research Topics

Disease

10Demyelinating Diseases (Demyelinating Disease)
01/2019 - 07/2005
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2018 - 07/2005
4Hypertension (High Blood Pressure)
08/2014 - 06/2006
4Proteinuria
01/2008 - 06/2006
3Kidney Diseases (Kidney Disease)
08/2014 - 12/2008
3Albuminuria
08/2014 - 12/2008
2Multiple Sclerosis
01/2017 - 07/2005
2Psoriasis (Pustulosis Palmaris et Plantaris)
11/2015 - 02/2007
2Obesity
01/2014 - 12/2006
1Inflammation (Inflammations)
01/2017
1Atrophy
10/2016
1Disease Progression
08/2014
1Type 2 Diabetes Mellitus (MODY)
01/2014
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2014
1Skin Diseases (Skin Disease)
06/2012
1Cardiovascular Diseases (Cardiovascular Disease)
02/2012
1Heart Diseases (Heart Disease)
02/2012
1Chronic Renal Insufficiency
12/2008
1Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2006
1Ganglion Cysts (Ganglion)
04/2006
1Connective Tissue Diseases (Connective Tissue Disease)
06/2005
1Cardiomyopathies (Cardiomyopathy)
06/2005
1Headache (Headaches)
06/2005

Drug/Important Bio-Agent (IBA)

6CuprizoneIBA
01/2019 - 09/2006
6AldosteroneIBA
01/2014 - 06/2006
5Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
01/2014 - 02/2007
4Kallikreins (Kallikrein)IBA
01/2018 - 02/2007
4Peptide Hydrolases (Proteases)FDA Link
01/2017 - 07/2005
4SaltsIBA
08/2014 - 06/2006
3Myelin Basic ProteinIBA
01/2019 - 03/2013
3Eplerenone (Inspra)FDA LinkGeneric
02/2007 - 06/2006
2SteroidsIBA
10/2016 - 08/2011
2GTP Phosphohydrolases (GTPases)IBA
08/2011 - 12/2008
2nephrinIBA
01/2008 - 12/2006
2Hydralazine (Apresoline)FDA LinkGeneric
02/2007 - 06/2006
2tempolIBA
02/2007 - 12/2006
2Messenger RNA (mRNA)IBA
09/2006 - 11/2005
2Myelin-Oligodendrocyte GlycoproteinIBA
11/2005 - 07/2005
1ParvalbuminsIBA
01/2019
1Luxol Fast Blue MBS (Luxol fast blue)IBA
12/2017
1Yi-Gan SanIBA
12/2017
1cyclohexanoneIBA
12/2017
1Proteinase-Activated ReceptorsIBA
01/2017
1GlucocorticoidsIBA
10/2016
1Imiquimod (Aldara)FDA LinkGeneric
11/2015
1OsmiumIBA
02/2015
1Renin InhibitorsIBA
08/2014
1aliskirenFDA Link
08/2014
1AngiotensinsIBA
08/2014
1Antihypertensive Agents (Antihypertensives)IBA
08/2014
1Angiotensin IIBA
08/2014
1Minocycline (Cyclops)FDA LinkGeneric
10/2013
1Ciliary Neurotrophic Factor (CNTF)IBA
10/2013
1Transcription Factors (Transcription Factor)IBA
08/2011
1Monomeric GTP-Binding ProteinsIBA
08/2011
1Guanine Nucleotide Dissociation Inhibitors (GDIs)IBA
12/2008
1AlbuminsIBA
01/2008
1Serine Proteases (Serine Protease)IBA
02/2007
1Superoxide DismutaseIBA
02/2007
1NADP (NADPH)IBA
02/2007
1Oxidoreductases (Dehydrogenase)IBA
02/2007
1Oxidants (Oxidizing Agents)IBA
12/2006
1DesminIBA
12/2006
1AntioxidantsIBA
12/2006
1Glutathione (Reduced Glutathione)IBA
09/2006
1TransferasesIBA
09/2006
1Proteins (Proteins, Gene)FDA Link
09/2006
1Aligeron (AS 2)IBA
06/2006
1methanesulfonate salt 2-hydroxy-4,4'-diamidinostilbeneIBA
04/2006
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
06/2005
1C-Reactive ProteinIBA
06/2005
1SodiumIBA
06/2005
1loxoprofen (CS 600)IBA
06/2005

Therapy/Procedure

1Therapeutics
01/2017